FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

ACUTAAS CHEMICALS LTD.

NSE : ACUTAASBSE : 543349ISIN CODE : INE00FF01025Industry : Pharmaceuticals & DrugsHouse : Private

BSE1468.05-7.05 (-0.48 %)

PREV CLOSE (Rs.) 1475.10

OPEN PRICE (Rs.) 1491.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1468.05 (454)

VOLUME 30841

TODAY'S LOW / HIGH (Rs.)1461.00 1510.00

52 WK LOW / HIGH (Rs.)696.02 1495.7

NSE1469.70-4.9 (-0.33 %)

PREV CLOSE( Rs. ) 1474.60

OPEN PRICE (Rs.) 1488.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1469.70 (597)

VOLUME 365442

TODAY'S LOW / HIGH(Rs.) 1460.50 1510.00

52 WK LOW / HIGH (Rs.)696.75 1498

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

452.76

Dividend Yield(%)

0.05

TTM EPS (Rs.)

23.27

P/E Ratio

63.10

Book Value (Rs.)

165.65

Face Value (Rs.)

MCap (Rs. in Mn)

120187.67

Price/Earning (TTM)

55.55

Price/Sales (TTM)

11.73

Price/Book (MRQ)

8.86

PAT Margin (%)

16.12

ROCE (%)

19.99

Incorporation Year : 12-06 2007

Management Info :

Nareshkumar Patel - Chairman Nareshkumar Patel - Managing Director

Registered Office :

Address : Plot No 440/5 & 6,Road No 82,G I D C Sachin,
Surat,
Gujarat-394230

Phone : 7227977744 / 7573015366

Email : info@acutaas.com

Website : www.acutaas.com

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

11Jul Acutaas Chemicals informs about certif
Acutaas Chemicals has informed that it enclosed the certificate dated Ju..

04Jun Acutaas Chemicals informs about analys
Acutaas Chemicals has informed that the Company’s Officials will attend..

20May Kotak Mahindra Mutual Fund buys 6.6% s
Kotak Mahindra Mutual Fund (Kotak MF) has bought a 6.6 per cent stake in..

Financials

	QTR Jun 25	ANNUAL 25
Net Profit	446.46	1595.47
Gross Profit	589.27	2135.76
Operating Profit	670.09	2434.78
Net Sales	2059.71	9898.35

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Cohance Lifesciences (BSE)

1011.20 (9.54%)

M.Cap (Rs. in Cr)38685.19

Procter&Gamble Healt (BSE)

6525.95 (0.94%)

M.Cap (Rs. in Cr)10832.67

Haleos Labs (BSE)

1169.00 (4.52%)

M.Cap (Rs. in Cr)353.42

Glaxosmithkline Phar (BSE)

2811.40 (1.48%)

M.Cap (Rs. in Cr)47626.81

Shareholding Pattern

	PROMOTERS	32.66%
	NON-INSTITUTION	28.01%
	MUTUAL FUNDS/UTI	16.27%
	FI/BANKS/INSURANCE	4.68%
	GOVERNMENT	0.01%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

SBI Healthcare Opp ...

2.97

Union Innovation & ...

2.78

Kotak Consumption F...

2.67

Bank of India ELSS ...

2.54

Union Small Cap Fun...

2.40

Samco Special Oppor...

2.29

Kotak Healthcare Fu...

2.27

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

ACUTAAS CHEMICALS LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives